GenoType ® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs

This Cochrane Review concludes that MTBDRsl (smear-positive specimen) identified most of the patients with second-line drug resistance. When the test reports a negative result, conventional testing for drug resistance can still be used.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news